Stephen Oh

Physician-scientist interrogating inflammatory cytokine-signaling networks in myeloproliferative neoplasms. #mpnsm. Co-Chief @WashUHematology.

[Stephen Oh @mpndoc]

I am thrilled to share that the news that I have been named the Samuel B. Grant Professor of Medicine! 🥳
I am deeply grateful to the extraordinary #OhTeam members, collaborators, mentors, colleagues, & friends whose support have made this journey possible! 🤩 @WashUHematology

[WashU Medicine Department of Medicine @WashUDeptMed]

#WashUDeptMed announces Stephen Oh, MD, was named the Samuel B. Grant Professor of Medicine. Dr. Oh is currently Co-Chief @WashUHematology and recognized for advancing the understanding of blood cancers, particularly myeloproliferative neoplasms.

Kudos> https://t.co/aQAGKizQ6i

[WashU Medicine Department of Medicine @WashUDeptMed]

Congratulations to the 2026 Department of Medicine Award recipients! Their outstanding contributions to patient care, research, education, mentorship and service exemplify the excellence that defines our department and advances the future of medicine.

> https://t.co/kNg3aKHE8f

[Stephen Oh @mpndoc]

Big time congrats to Nicole and kudos to all of our deserving @WashUHematology nominees! 🙌 Such a wonderful event to celebrate the many amazing people in our @WashUDeptMed! 🤩

[WashU Medicine Division of Hematology @WashUHematology]

Congratulations to Nicole Gaudin and Hematology nominees who were honored at the 2026 Department Awards ceremony. To see a list of all Hematology Division members who were nominated for a DOM award, visit https://t.co/neq9ugg2wQ

[Grant Challen @challenlab]

As you can see, our lab is desperately in need of a new post doc to replace those who have left us. Interested candidates apply here, please repost and spread the word!

https://t.co/kJgalIy46g

[Stephen Oh @mpndoc]

Congrats @LindaResar well deserved!!! 🤩

[Naveen Pemmaraju, MD @doctorpemm]

👏👏👏Congratulations to Dr @LindaResar for her lifetime achievement of work in winning the 2026 Award 🥇 for Excellence in Translational Research at the 18th International Congress on MPNs in Brooklyn NY !! #MPNSM | @PedsHemeDoc @mpdrc @nsarellano9 @homesforhealers

[WashU Medicine Department of Medicine @WashUDeptMed]

Stephen T. Oh, MD, PhD, Grant A. Challen, PhD, Daniel C. Link, MD and colleagues have received an NIH grant to study how inflammation drives blood cancers, advancing research that could lead to new therapies for patients with myeloproliferative neoplasms.

https://t.co/odeYTgyFC1

[WashU Medicine Division of Hematology @WashUHematology]

In a study led by Dr. Stephen Oh, researchers at WashU Medicine have identified a possible route to tame inflammation in myeloproliferative neoplasms — a group of chronic blood cancers — that could serve as a novel approach to treatment.

https://t.co/DjjX2dQnBl

[Stephen Oh @mpndoc]

Sadly not able to stay and fully experience The Most Magical Place on Earth but big thank you 🙏 @md_padron for inviting me to speak at the inaugural Translational Myeloid Conference chock full of stimulating talks from many leaders in the field! @MoffittNews #disneycaricature

[WashU Medicine Division of Hematology @WashUHematology]

The NIH has awarded WashU Medicine an $11.7 million grant to study how inflammation drives myeloproliferative neoplasms, a group of blood cancers at high risk of progressing to acute myeloid leukemia. https://t.co/uvbsmfCBmL

[Stephen Oh @mpndoc]

@WashUGenetics @YangEricLi Awesome news congrats @YangEricLi! 🥳

[Raajit Rampal, M.D.Ph.D. @RaajitRampal]

Why do some pts with MPNs stay stable for decades while others progress? @MPN_RF launched the MPN Progression Research Network in 2020 to address this pressing issue. We now present a blueprint for dealing with progression from these efforts. (https://t.co/qW75e4aVja).A thread🧵

[WashU Medicine Division of Hematology @WashUHematology]

A study by WashU hematology researchers shows that a novel blood-based digital PCR test can detect when treatment is failing a median of three months before standard of care testing identifies treatment failure. Findings published in Haematologica. https://t.co/dvQyzNhDRn

[WashU Medicine Division of Hematology @WashUHematology]

The findings from a study led by WashU hematology’s Yoon-A Kang, PhD, were recently published in Blood Advances. Researchers discovered how unfolded protein response signaling promotes myeloid cell production and cooperates with oncogenic mutation. https://t.co/ht42XniIT0

[Stephen Oh @mpndoc]

@GabyHobbs Thank you so much @GabyHobbs for sharing your insights with our patients and loved ones! Also glad you got an opportunity to see the Arch (and were wise enough to not "invite" @KuykendallMd on your early morning "stroll"! 😃

[Stephen Oh @mpndoc]

I am so proud of the important and impactful work from our WashU MPN program, and I am excited by the positive momentum for the MPN field more broadly! 🙏

Stay tuned for more exciting news for our WashU MPN program, details to be shared soon! 😃

@WashUDeptMed
@SitemanCenter

[Stephen Oh @mpndoc]

What an incredible past few days for our @washumedicine MPN program! 🤩 #mpnsm

[Stephen Oh @mpndoc]

And on Saturday, we were honored to be joined by
@GabyHobbs & @KuykendallMd for our MPN patient education program. Attended by more than 100 patients & guests, the event provided an opportunity to learn about current and emerging approaches to diagnosis and management of MPNs. 4/

[WashU Medicine Division of Hematology @WashUHematology]

Promising target identified against chronic blood cancer. The study is led by Stephen Oh, MD, PhD, Co-Director of the Division of Hematology at WashU Medicine.
https://t.co/GUaGXhGcO1